Peripartal treatment with low‐dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone

Peripartal treatment with low‐dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone

Abstract Women mobilize up to 10% of their bone mass during lactation to provide milk calcium. About 8%–13% of mothers use selective serotonin reuptake inhibitors (SSRI) to treat peripartum depression, but SSRIs independently decrease bone mass. Previously, peripartal use of the SSRI fluoxetine redu...

Full description

Bibliographic Details
Main Authors: Celeste M. Sheftel, Luma C. Sartori, Emily R. Hunt, Robbie S. J. Manuel, Autumn M. Bell, Rafael R. Domingues, Lella A. Wake, Brandon R. Scharpf, Chad M. Vezina, Julia F. Charles, Laura L. Hernandez
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Physiological Reports
Subjects:
bone
lactation
mammary gland
serotonin
SSRI
Online Access:https://doi.org/10.14814/phy2.15204

Internet

https://doi.org/10.14814/phy2.15204

Similar Items